港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AI醫療

674.532

+16.5542.52%

漲家數：8

跌家數：- -

平家數：- -

市盈率：- -

高：677.899

開：657.401

低：653.797

收：657.977

成交量：1.70億

成交額：14.89億

市值：1,921.82億

流通市值：1,889.90億

資料載入中...

總覽新聞資訊

省會如何強？支點怎麼建？來看這些地方樣本

21世纪经济报道

港股異動 | 愛康醫療(01789)再升逾8% 骨科手術機器人銷售收入增速超200%

印尼衞生部部長到訪醫渡科技(02158) 深化戰略合作

智雲健康經營現金流首迎轉正

南方财经网

吳泳銘和蔣凡是畫圈還是畫餅？

經營現金流首迎轉正，智雲健康（9955.HK）「AI+P2M」打通慢病商業化閉環

《業績》微創機器人(02252.HK)全年虧損收窄至2.5億人民幣

阿斯达克财经

智雲健康(09955)發布年度業績收入16.23億元毛利7.75億元

醫渡科技(02158)授權受託人根據股份獎勵計劃從市場購買股份

中國臨床循證智能能力建設計劃啓動醫渡智循亮相中關村論壇年會

愛康醫療(01789.HK)3月26日耗資718.8萬港元回購119.4萬股

阿里健康(00241)出現大手賣出110萬股，成交價$4.7，涉資517萬

阿斯达克财经

平安好醫生(01833)股價下跌7.451%，現價港幣$11.8

阿斯达克财经

「AI製藥」的晶泰控股扭虧虛與實

华尔街见闻

港股異動 | 微創機器人-B(02252)績前升逾3% 公司預計去年收入最高按年增長120%

AI for Science第一股晶泰控股（2228.HK）首次盈利，AI」養蝦」時代迎來收網者

平安好醫生(01833)2025年報發出了一個關鍵信號

【券商聚焦】中信建投：醫療器械板塊拐點來臨，26年業績改善個股存在業績估值修復機會

晶泰控股(02228)首次全年盈利：稀缺「AI+機器人」平台進入價值兑現期

愛康醫療(01789)發布年度業績股東應占年度溢利3.39億元按年增加23.8%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/BK1617/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1617\",,,,,undefined,":{"symbol":"BK1617","market":"HK","secType":"PLATE","nameCN":"AI醫療","latestPrice":674.5316,"timestamp":1774598898612,"preClose":657.9772,"halted":0,"volume":170184313,"delay":0,"changeRate":0.02516,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":16.554443,"latestTime":"03-27 16:00:00","open":657.40137,"high":677.8986,"low":653.79675,"amount":1488692619,"amplitude":0.03663,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"pbRate":3.590911,"peRate":140.323929,"turnoverRate":0.006235,"increases":7,"decrements":1,"flats":0,"marketCap":192181712768,"floatMarketCap":188989786496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1617\",,,,,undefined,":{"symbol":"BK1617","high":677.8986,"amplitude":0.03663,"preClose":657.9772,"low":653.79675,"pbRate":"3.590911","latestPrice":674.5316,"volume":170184313,"delay":0,"open":657.40137,"prevYearClose":701.14185,"prevWeekClose":669.975,"prevMonthClose":757.65,"prevQuarterClose":701.142,"fiveDayClose":669.975,"twentyDayClose":757.65,"sixtyDayClose":717.18,"secType":"PLATE","market":"HK","turnoverRate":0.006235,"peRate":140.323929,"marketCap":192181712768,"floatMarketCap":188989786496,"timestamp":1774598898612,"nameCN":"AI醫療"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1617\",,,,undefined,":{"bkCode":"BK1617","up":8,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1617\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622822778","title":"省會如何強？支點怎麼建？來看這些地方樣本","url":"https://stock-news.laohu8.com/highlight/detail?id=2622822778","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622822778?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 21:18","pubTimestamp":1774617480,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者 李果 吴文汐 成都 武汉报道2026年开年，地方的“强省会”与“强支点”深度推进，折射出地方发展逻辑的调整。表面看，这是“强省会”与“强支点”两种路径。2026年2月24日，湖北省召开“全省加快建成中部地区崛起的重要战略支点推进大会”。这是湖北省连续第二年“新春第一会”聚焦支点建设。四川省人民政府决策咨询委员会副主任李后强表示，四川地域广阔，地理差异明显，各地区发展不平衡问题长期存在。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-03-27/doc-inhsmxrr8157909.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-03-27/doc-inhsmxrr8157909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1617","BK1571","00241","BK1515","BK1589","BK1247","BK1610","BK1615","BK1502","BK1142","BK1501","BK1591","BK1189","BK1584"],"gpt_icon":0},{"id":"2622773845","title":"港股異動 | 愛康醫療(01789)再升逾8% 骨科手術機器人銷售收入增速超200%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622773845","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622773845?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 15:53","pubTimestamp":1774598020,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，爱康医疗再涨超8%，截至发稿，涨7.92%，报6.27港元，成交额6289.9万港元。消息面上，爱康医疗此前发布年度业绩，全年收入人民币14.82亿元，同比增加10.1%；公司权益股东应占年度溢利3.39亿元，同比增加23.8%。其中，骨科手术机器人销售收入增速超过200%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ROBO","01789","BK4588","BK1583","VXUS","BK1617","BK1100","BK1585","BK4585"],"gpt_icon":0},{"id":"2622814785","title":"印尼衞生部部長到訪醫渡科技(02158) 深化戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2622814785","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622814785?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 12:35","pubTimestamp":1774586138,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月26日，印度尼西亚卫生部部长布迪·古纳迪一行到访医渡科技北京总部，与医渡科技创始人、董事长宫如璟举行会谈。双方围绕深化中印尼数字健康合作、推动印尼国家医疗体系数字化升级等议题深入交流。此次访问正值印尼全力推进“2045黄金印尼愿景”的关键阶段。作为全球第四人口大国，印尼正将医疗健康数字化转型作为国家发展重点，在提升医疗可及性、应对慢病负担与构建韧性卫生体系方面存在迫切需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","02158","BK1518","BK1189"],"gpt_icon":0},{"id":"2622192158","title":"智雲健康經營現金流首迎轉正","url":"https://stock-news.laohu8.com/highlight/detail?id=2622192158","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622192158?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 11:03","pubTimestamp":1774580580,"startTime":"0","endTime":"0","summary":"南方财经3月27日电，智云健康（09955.HK）发布2025年度业绩公告，实现上市以来首次经营活动现金流入净额转正，金额达6684万元，迈入自主造血的发展新阶段。在Al+P2M战略指引下，院内院外的订阅收入和P2M收入整体达8.5亿元，同比增长28.7%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686768655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","BK1617","159399","09955"],"gpt_icon":0},{"id":"2622815081","title":"吳泳銘和蔣凡是畫圈還是畫餅？","url":"https://stock-news.laohu8.com/highlight/detail?id=2622815081","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622815081?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 09:59","pubTimestamp":1774576752,"startTime":"0","endTime":"0","summary":"市场用脚投票的背后，是一个更尖锐的问题：吴泳铭和蒋凡主导的这场\"即时零售豪赌\"，究竟是在为阿里画出第二增长曲线的\"圈\"，还是在给投资者描绘一个遥不可及的\"饼\"？2024年11月21日，阿里巴巴集团CEO吴泳铭通过全员邮件宣布成立阿里电商事业群，任命蒋凡担任CEO，全面整合国内和海外电商业务。蒋凡带来的改变是立竿见影的。但这是\"画圈\"还是\"画饼\"，最终还是要落到财报上来：新增GMV能否转化为可持续的利润？","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774322738691892434","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1589","BK1591","BK1615","BK1584","BK1617","BK1515","BK1571","BK1610","BK1502","BK1189","BK1142","BK1501","BK1247","00241"],"gpt_icon":0},{"id":"2622779818","title":"經營現金流首迎轉正，智雲健康（9955.HK）「AI+P2M」打通慢病商業化閉環","url":"https://stock-news.laohu8.com/highlight/detail?id=2622779818","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622779818?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 08:55","pubTimestamp":1774572949,"startTime":"0","endTime":"0","summary":"实现上市以来首次经营活动现金流入净额转正，金额达6684万元","market":"us","thumbnail":"https://img7.gelonghui.com/column/10.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/10.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4202233","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["AGIX","AIPO","09955","BK1617","159399","CHAT","BK1197"],"gpt_icon":0},{"id":"2622864505","title":"《業績》微創機器人(02252.HK)全年虧損收窄至2.5億人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2622864505","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622864505?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 23:27","pubTimestamp":1774538820,"startTime":"0","endTime":"0","summary":"微创机器人－Ｂ(02252.HK) 公布2025年度业绩，收入录得5.51亿人民币(下同)，按年增加114.2%。亏损由上年度6.42亿元，收窄至2.5亿元，主要由于营收增长和降本增效措施带动毛利增加、提升研发及运营效率令经营费用下降以及减值拨备减少；每股亏损24分。不派末期息。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-26 16:25。)过往派息公布日期派息事项派息内容2025/08/28中期业绩无派息2025/03/27末期业绩无派息2024/08/28中期业绩无派息2024/03/27末期业绩无派息AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220216125658513_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220216125658513_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513009/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513009/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["CNHmain","02252","CYB","BK1100","UCmain","MCNHmain","BK1617","MUCmain"],"gpt_icon":0},{"id":"2622117869","title":"智雲健康(09955)發布年度業績 收入16.23億元 毛利7.75億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622117869","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622117869?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 22:41","pubTimestamp":1774536071,"startTime":"0","endTime":"0","summary":"智通财经APP讯，智云健康 发布截至2025年12月31日止年度的年度业绩，收入16.23亿元;毛利7.75亿元;毛利率为47.8%。院外解决方案的毛利率由截至2024年12月31日止年度的23.1% 大幅增至截至2025年12月31日止年度的47.2%，主要是由于我们进行业务重组以重点打造高质量及可产生现金流的增长，导致主动减少低利润率药店增值解决方案所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","BK1197","09955"],"gpt_icon":0},{"id":"2622261863","title":"醫渡科技(02158)授權受託人根據股份獎勵計劃從市場購買股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2622261863","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622261863?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 21:33","pubTimestamp":1774531980,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技(02158)发布公告，公司董事会已授权公司指示获委任管理首次公开发售后股份奖励计划的独立专业受托人根据首次公开发售后股份奖励计划的规则按现行市价于市场上购买公司股份。董事会认为，维持以具竞争力价格购入的股份储备，将提升集团在构建有效补偿与薪酬组合方面的灵活性，从而加强其吸引及留任集团持续增长及发展所需人才的能力。股份购买将根据公司需求并参考当前市况而作出。受托人购买的任何股份将由受托人根据公司与受托人订立的构成首次公开发售后股份奖励计划的信托契据所载明的目的及以计划规则而持有。所付金额(如有)将由公司内部财务资源拨付，将不会影响公司营运。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1617","02158","BK1518"],"gpt_icon":0},{"id":"2622385078","title":"中國臨床循證智能能力建設計劃啓動 醫渡智循亮相中關村論壇年會","url":"https://stock-news.laohu8.com/highlight/detail?id=2622385078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622385078?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 20:52","pubTimestamp":1774529552,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月26日，2026中关村论坛年会“世界数字健康论坛”发布一批“医疗科技创新成果”，“中国临床循证智能能力建设计划”作为其重大成果之一在会上正式启动。本次启动的“中国临床循证智能能力建设计划”正是为回应这一结构性痛点而设。在中关村论坛上启动的“中国临床循证智能能力建设计划”，不仅是一次行业协同的起点，更是中国医疗“证据驱动决策”向智能化、普惠化迈进的重要标志。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK0178","BK0075","BK1617","000931","BK0028","BK1518","02158","BK0239"],"gpt_icon":0},{"id":"2622386852","title":"愛康醫療(01789.HK)3月26日耗資718.8萬港元回購119.4萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622386852","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622386852?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 19:37","pubTimestamp":1774525023,"startTime":"0","endTime":"0","summary":"格隆汇3月26日丨爱康医疗(01789.HK)发布公告，2026年3月26日耗资718.8万港元回购119.4万股，回购价格每股6.02港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260326/32101954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1617","BK1585","01789","BK1100","BK1583"],"gpt_icon":0},{"id":"2622813834","title":"阿里健康(00241)出現大手賣出110萬股，成交價$4.7，涉資517萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2622813834","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622813834?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 15:20","pubTimestamp":1774509600,"startTime":"0","endTime":"0","summary":"[大手成交]阿里健康(00241)在下午03:20出现大手卖出，成交量为110万，成交价为港币$4.7，涉资517万。至目前为止，股价跌4.082%，今日最高价为$4.9，而最低价为$4.7，总成交量为5.355千万股，总成交金额港币$2.558亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603266539/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603266539/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1571","00241","BK1610","BK1501","BK1142","BK1617","BK1247","BK1589","BK1515","BK1584","BK1189","BK1615","BK1502","BK1591"],"gpt_icon":0},{"id":"2622839036","title":"平安好醫生(01833)股價下跌7.451%，現價港幣$11.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2622839036","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622839036?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 14:55","pubTimestamp":1774508100,"startTime":"0","endTime":"0","summary":"[下跌股]平安好医生(01833) 股价在下午03:00比前收市价下跌7.451%，现股价为港币$11.8。至目前为止，今日最高价为$11.8，而最低价为$11.8。总成交量为400股，总成交金额为港币$4720。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603264128/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603264128/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1247","BK1571","BK1617","01833","BK1615","BK1515","BK1142","BK1219"],"gpt_icon":0},{"id":"2622783996","title":"「AI製藥」的晶泰控股扭虧虛與實","url":"https://stock-news.laohu8.com/highlight/detail?id=2622783996","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622783996?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 14:52","pubTimestamp":1774507932,"startTime":"0","endTime":"0","summary":"港股“AI制药明星企业”晶泰控股交出了上市以来的首份扭亏答卷。\n2025年，晶泰控股实现营业收入8....","market":"sh","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3768447","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768447","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“AI制药”的晶泰控股扭亏虚与实","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01477","02228","BK1574","BK1617","AGIX","CHAT","BK1191","AIPO"],"gpt_icon":0},{"id":"2622836439","title":"港股異動 | 微創機器人-B(02252)績前升逾3% 公司預計去年收入最高按年增長120%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622836439","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622836439?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 14:38","pubTimestamp":1774507106,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创机器人-B(02252)绩前涨超3%，截至发稿，涨3.64%，报25.06港元，成交额2.06亿港元。消息面上，微创机器人拟3月26日举行董事会会议，以考虑及通过集团截至2025年12月31日止年度的全年业绩及公布。该公司此前披露，预期公司截至2025年12月31日止年度的收入同比增长约110%至120%，经调整净亏损不超过2.40亿元，同比缩窄超过50%。收入大幅跃升主要归因于核心产品图迈®腔镜手术机器人商业化取得突破性进展，销售增长迅猛，尤其是图迈海外市场拓展成效显著，全年新签海外市场订单逾百台，全年海外市场销售收入为去年的五倍以上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","BK4588","BK4585","BK1100","VXUS","02252"],"gpt_icon":0},{"id":"2622835062","title":"AI for Science第一股晶泰控股（2228.HK）首次盈利，AI」養蝦」時代迎來收網者","url":"https://stock-news.laohu8.com/highlight/detail?id=2622835062","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622835062?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 14:22","pubTimestamp":1774506144,"startTime":"0","endTime":"0","summary":"从“养虾”到“收网”，晶泰不仅实现了自身的商业突破，更为AI行业指明方向：唯有扎根产业、解决实际痛点，才能让AI从实验室走向产业端，从烧钱工具变成真正的“产业印钞机”。","market":"fut","thumbnail":"https://img2.gelonghui.com/b17e2-e0cfaa5e-109d-4095-af66-113a43a6a2c8.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-e0cfaa5e-109d-4095-af66-113a43a6a2c8.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e1d988722ff66852c525a3ca4fcad38d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4195672","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1141","BK1617","AIPO","CHAT","02228","AGIX"],"gpt_icon":0},{"id":"2622887959","title":"平安好醫生(01833)2025年報發出了一個關鍵信號","url":"https://stock-news.laohu8.com/highlight/detail?id=2622887959","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622887959?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 11:26","pubTimestamp":1774495564,"startTime":"0","endTime":"0","summary":"平安好医生2025年年报财报中有许多有意思的内容。根据智通财经APP的统计，32.41%的毛利率，创造了平安好医生自2018年以来的新高，彼时此一数据是27.32%;且自2023年以来，平安好医生的毛利率一直维持在30%以上的高位。在平安好医生业绩发布前后，包括花旗、美银等多家券商纷纷发布研报，看高该公司2026年的业绩成长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1571","01833","BK1617","BK1247","BK1219","BK1515","BK1615","BK1142"],"gpt_icon":0},{"id":"2622818008","title":"【券商聚焦】中信建投：醫療器械板塊拐點來臨，26年業績改善個股存在業績估值修復機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818008","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622818008?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 09:18","pubTimestamp":1774487918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投表示，医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1515","02252","601066","BK1589","02235","00853","BK1161","BK1222","BK1585","BK1100","BK1587","BK1610","BK1247","LU0287142896.SGD","BK0276","09996","BK1142","BK1617","BK1501","BK1615","09997","BK1584","159883","LU0173614495.USD","BK1591","01302","BK1600","BK1571","BK1502","BK1189","02190","01066","BK1583","00241","06826","BK1574"],"gpt_icon":0},{"id":"2622688504","title":"晶泰控股(02228)首次全年盈利：稀缺「AI+機器人」平台進入價值兑現期","url":"https://stock-news.laohu8.com/highlight/detail?id=2622688504","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622688504?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 08:23","pubTimestamp":1774484585,"startTime":"0","endTime":"0","summary":"3月25日，晶泰控股2025年年度业绩新鲜出炉。晶泰控股由此成为AI for Science领域首家盈利港股上市公司。“AI+机器人”平台价值迈入规模化兑现在当下外部因素干扰引发整体市场波动背景下，投资者更愿意为明确的价值兑现支付溢价。2025年，晶泰控股之所以能首次实现全年度盈利，直接驱动因素之一便在于公司药物发现解决方案业务实现长足的收入增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e1d988722ff66852c525a3ca4fcad38d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","AIPO","CHAT","ROBO","02228","AGIX","BK1141"],"gpt_icon":0},{"id":"2622703077","title":"愛康醫療(01789)發布年度業績 股東應占年度溢利3.39億元 按年增加23.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622703077","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622703077?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 23:10","pubTimestamp":1774451449,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱康医疗 发布截至2025年12月31日止年度业绩，该集团取得收入人民币14.82亿元，同比增加10.1%;公司权益股东应占年度溢利3.39亿元，同比增加23.8%;每股基本盈利0.304元，拟派发末期股息每股11.8港仙。2025年，在带量采购政策推动下，进一步加速进口替代，公司产品的手术量需求持续增长。本集团截至2025年12月31日止年度实现净利润人民币 3.39亿元，较2024年同期显著增长23.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK1583","BK1617","01789","BK1100"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}]}}